[Case of heterochronous triple urogenital cancer (renal cell carcinoma, bladder cancer, prostatic cancer)]
| Autor: | Akiou Okumura, Kiyoshi Takagawa, Hideki Fuse, Shinji Tsuritani |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
medicine.medical_specialty Urology Enucleation Adenocarcinoma urologic and male genital diseases Neoplasms Multiple Primary medicine Carcinoma Humans Microhematuria Carcinoma Renal Cell Aged Bladder cancer business.industry Genitourinary system Cancer Prostatic Neoplasms medicine.disease medicine.icd_9_cm_classification Kidney Neoplasms Clear cell renal cell carcinoma Treatment Outcome Urinary Bladder Neoplasms business Follow-Up Studies |
| Zdroj: | Nihon Hinyokika Gakkai zasshi. The japanese journal of urology. 104(6) |
| ISSN: | 0021-5287 |
| Popis: | We report a case of a 73-year-old male with heterochronous triple urogenital cancer. The patient was referred to our hospital because serum PSA was elevated (7.0 ng/ml) in 1998. Prostatic needle biopsy revealed prostatic cancer in the right lobe, and total prostatectomy was performed. The histopathological diagnosis was moderately differentiated adenocarcinoma (TlcNOMO). Non-muscle invasive bladder cancer (NMIBC) was detected during an examination for microhematuria in 2002. Transurethral resection of the bladder tumor (TURBT) procedure was performed, and the histopathological diagnosis was grade 2 urothelial carcinoma (pTa). A right renal mass was detected incidentally on follow-up CT for bladder cancer in 2008. Renal enucleation was performed in 2009. The histopathological diagnosis was grade 2 clear cell renal cell carcinoma (pTlaNXMO). NMIBC was detected on follow-up urethrocystoscopy in 2011. The TURBT procedure was performed, and the histopathological diagnosis was grade 2 urothelial carcinoma (pTa). On follow-up for urogenital cancer patients, it is important to investigate recurrence of the primary cancer and also heterochronous canceration of other urogenital organs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|